NCT01748448 2025-02-17
ViDMe
Universitaire Ziekenhuizen KU Leuven
Phase 3 Completed
Clinical Trials
10 trialsNCT01224678 2024-10-08
Vitamin D and Breast Cancer Biomarkers in Female Patients
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00365105 2024-09-20
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT03078855 2024-09-04
ILyAD
University of Rochester
Phase 3 Completed
NCT00452439 2020-12-28
A Study of Actonel for the Prevention of Bone Loss
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00079001 2020-05-12
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00329797 2017-11-29
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00186901 2017-05-10
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
St. Jude Children's Research Hospital
Phase 3 Completed
NCT00352846 2013-07-02
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00171925 2012-04-11
Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
Novartis
Phase 3 Terminated